Stock listing

Frankfurt:8C5 Coherus Oncology, Inc. Aktie

German listing (Frankfurt) of Coherus Oncology, Inc. · home listing NASDAQ:CHRS

Follow Coherus Oncology, Inc. into a list and get an email when it puts out news.

Share price · FWB:8C5

€0.784 EUR -0.106 (-12.0%)

Close on Oct 30, 2026

Day range
€0.784 – €0.784 EUROct 30, 2026
Market cap
€121.1M EURAt the close on Oct 30, 2026 · price × 154.5M shares outstanding
Coherus Oncology, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:CHRS · Home$0.749 USD-0.081 (-9.7%)2,608,622$0.835$0.838$0.746$0.830Close on Nov 2, 2026
Frankfurt:8C5€0.784 EUR-0.106 (-12.0%)—€0.784€0.784€0.784€0.891Close on Oct 30, 2026
Ticker
Frankfurt:8C5
Asset type
Stock
Exchange
Frankfurt
Currency
EUR

What changed lately

Calls

Upcoming

  • Coherus Oncology (NASDAQ:CHRS) Q3 2026 Earnings Call

    Mon, Nov 09, 2026 · 5:00 PM ET

    Register

Replays

  • Coherus Oncology (NASDAQ:CHRS) Q2 2026 Earnings Call

    Wed, Aug 05, 2026 · 5:00 PM ET

    Watch Transcript
  • Coherus Oncology (NASDAQ:CHRS) Q1 2026 Earnings Call

    Mon, May 11, 2026 · 5:00 PM ET

    Watch Transcript
  • Coherus Oncology (NASDAQ:CHRS) Q4 2025 Earnings Call

    Mon, Mar 09, 2026 · 4:30 PM ET

    Watch Transcript

Latest news

All Coherus Oncology, Inc. news

Decks

Coherus Oncology, Inc. on 6ix

News releases
24 in the last 12 months · 160 in all · newest Oct 28, 2026 · oldest 2019
Calls
23 calls with a replay · 23 with a transcript · latest Aug 5, 2026
Decks
4 decks · latest September 2026

Where Coherus Oncology, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:CHRS · Home listingNASDAQUnited StatesUSD
Tradegate:8C5TradegateGermanyEUR
gettex:8C5gettexGermanyEUR
Lang & Schwarz:A12ETZLang & SchwarzGermanyEUR
LS Exchange:A12ETZLS ExchangeGermanyEUR
BOATS:CHRSBOATSUnited StatesUSD
BX Swiss:8C5BX SwissSwitzerlandCHF
Dusseldorf:8C5DusseldorfGermanyEUR
Frankfurt:8C5 · This pageFrankfurtGermanyEUR
Munich:8C5MunichGermanyEUR
Stuttgart:8C5StuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Coherus Oncology, Inc.